Search
News
Roswell Park Study Reveals How Venetoclax Boosts Immune Response to CAR T for Chronic Lymphocytic Leukemia
… Response to CAR T for Chronic Lymphocytic Leukemia Dr. Matthew Cortese highlights new findings in talk at American Society … (CLL), the most common type of leukemia in the U.S. Matthew Cortese, MD, MPH , Assistant Professor of Oncology in … (CLL), the most common type of leukemia in the U.S. Matthew Cortese, MD, MPH , Assistant Professor of Oncology in …
News
Roswell Park Experts Report Insights on CAR T for Follicular Lymphoma, KEYNOTE-667 Combo in Hodgkin Lymphoma
… Oral abstracts at ASH 2024 highlight studies led by Drs. Matthew Cortese and Kara Kelly Study clarifies impact of CAR T-cell … That’s the conclusion of a retrospective study led by Matthew Cortese, MD, MPH , Assistant Professor of Oncology in … That’s the conclusion of a retrospective study led by Matthew Cortese, MD, MPH , Assistant Professor of Oncology in …
News
Tandem 2025: Roswell Park Team Creates Predictive Model to Inform Care of Lymphoma Patients
… Adults undergoing Stem cell transplantation) Consortium.” Matthew Cortese, MD, MPH , Assistant Professor of Oncology, … on the work. Marco Davila, MD, PhD Theresa Hahn, PhD Matthew Cortese, MD, MPH Showkat Hamid, MD ### From the … Adults undergoing Stem cell transplantation) Consortium.” Matthew Cortese, MD, MPH , Assistant Professor of Oncology, …
News
Roswell Park Experts to Showcase Groundbreaking Hematology Research at 66th ASH Annual Meeting
… oral abstracts On Saturday, Dec. 7, at 10:45 a.m., Matthew Cortese, MD, MPH , will present abstract 78, Multiomic … Grand Hyatt San Diego). On Sunday, Dec. 8, at 10 a.m., Dr. Cortese will present abstract 525, Clinical Outcomes of … oral abstracts On Saturday, Dec. 7, at 10:45 a.m., Matthew Cortese, MD, MPH , will present abstract 78, …